Showing results (181-190 of 315) with videos related to
Sort By:
Pageof 32
Surgery|March 1, 1976
Cessation of immunosuppression after renal transplantationD T Uehling, J L Hussey, A B Weinstein, et al.Human Immunology|May 1, 1985
Analysis of human class II antigens by cloned cytolytic T cell reagents: a study using HLA loss mutant lymphoblastoid cell lines and monoclonal antibodies detecting the HLA-DP product(s)N Ohta, A Anichini, N L Reinsmoen, et al.The Journal of Clinical Investigation|February 15, 1997
Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa BJ Anrather, V Csizmadia, C Brostjan, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1991
Regulation of murine splenocyte responses by heparan sulfateL E Wrenshall, F B Cerra, A Carlson, et al.Transplantation|October 1, 1991
Polyreactivity and antigen specificity of human xenoreactive monoclonal and serum natural antibodiesM A Turman, P Casali, A L Notkins, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1987
Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -betaA C Ochoa, G Gromo, B J Alter, et al.Science (New York, N.Y.)|June 27, 1975
HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytesM J Sheehy, P M Sondel, M L Bach, et al.Transplantation|November 24, 1998
Regulated and endothelial cell-specific expression of Fas ligand: an in vitro model for a strategy aiming at inhibiting xenograft rejectionT H Tran, S Grey, J Anrather, et al.Transplantation|December 1, 1993
In vivo depletion of xenoreactive natural antibodies with an anti-mu monoclonal antibodyM P Soares, D Latinne, M Elsen, et al.Transplantation|November 1, 1990
Endothelial cell antigens recognized by xenoreactive human natural antibodiesJ L Platt, B J Lindman, H Chen, et al.Pageof 32